We examined the effect of core and skin temperature on the accuracy of two pulse oximeters (Nellcor Symphony and Hewlett Packard saturation module, M1020A) and a transcutaneous PCO 2 monitor (Fastrac Transcutaneous monitor) immediately after cardiac surgery in a group of newborns and infants. Seventy-nine sets of data were collected from 46 patients. Core temperatures ranged from 35.3°C to 39.4°C, skin temperatures ranged from 27.0°C to 37.4°C and core-skin temperature gradients ranged from 0.1°C to 10.1°C. Data analysis consisted of comparing the difference between transcutaneous PCO 2 and arterial PCO 2 and the differences between oxygen haemoglobin saturation measured by both pulse oximeters and oxygen haemoglobin saturation measured by co-oximeter to core temperature, skin temperature and core-skin temperature gradients. The mean differences±standard deviations and limits of agreement for transcutaneous PCO 2 and oxygen haemoglobin saturation measured by the Hewlett Packard and Nellcor pulse oximeters were 0.95±4.10 mmHg , -1.07±1.84% (-4.68% to 2.54%) and -1.23±2.23% (-5.60% to 3.14%) respectively. Analysis of correlation coefficients showed that the accuracy of the transcutaneous PCO 2 monitor and the pulse oximeters were not affected by core temperature, skin temperature or core-skin temperature gradient in the ranges encountered. We therefore conclude that these devices are acceptably accurate and suitable for use in infants when core and skin temperatures and core-skin temperature gradient are in the range normally found after cardiac surgery.
The ability to measure blood oxygenation and carbon dioxide level is an important minimum requirement of intensive care. Both can be monitored non-invasively: oxygen when using pulse oximetry and carbon dioxide using a transcutaneous PCO 2 monitor. Both of these non-invasive measurement techniques are simple and provide information continuously but their accuracy depends on skin blood flow. Pulse oximeters require pulsatile flow under the probe 1 and transcutaneous monitors require adequate blood flow in the skin below the electrode 2,3 . As a result, reduction of cutaneous blood flow can impair the performance of pulse oximeters and of transcutaneous PCO 2 monitors.
Cardiac surgery in children usually involves intraoperative cooling. On admission to intensive care after surgery, the core and skin temperatures are often low, and skin vasoconstriction often persists during core re-warming as part of the inflammatory response or as a cardiovascular homeostatic reflex. This produces a temperature gradient between core and skin and reduces cutaneous blood flow during the postoperative period 4 . The aim of this study was to quantify the accuracy of two pulse oximeters and a transcutaneous PCO 2 monitor and to examine the effect of core and skin temperature on this accuracy in a group of newborns and infants immediately after cardiac surgery.
MATERIALS AND METHODS
Postoperative cardiac surgical patients less than approximately 12 months of age and with haemoglobin saturation measured by pulse oximeter to be greater than 75% at the time of data collection were eligible for the study. Approval for the study was obtained from the Hospital Ethics Committee and informed consent was obtained. On arrival in intensive care after surgery, patients had transcutaneous PCO 2 (TcCO 2 ) and haemoglobin saturation recorded. TcCO 2 was recorded using the Fastrac Transcutaneous CO 2 monitor (Sensormedics, Yorba Linda, CA, U.S.A.). In each child, haemoglobin saturation was recorded using both a Hewlett Packard saturation module (M1020A, Hewlett Packard, Andover, MA, U.S.A.) as part of the Hewlett Packard Component Monitoring System and a Nellcor Symphony pulse oximeter (Nellcor Puritan Bennett, Pleasanton, CA, U.S.A.). The electrode membrane of the Fastrac was replaced and the device calibrated prior to each use and the Fastrac was manually checked for drift after each use. Rectal (core) and skin temperatures were measured using YSI 400 series probes (401, 402 or 409B, Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A.). Skin temperature was recorded from the plantar skin surface of the foot (skin temperature).
The TcCO 2 monitor was operated at an electrode temperature of 43°C. The electrode was placed on the upper abdomen, chest or, in a small number of cases, the thigh. The electrode was allowed to stabilize for approximately 20 minutes before the first recordings were made. Oxygen saturation readings were made using Nellcor oximeter probes (I-20 or D-20, Nellcor Puritan Bennett Inc, Pleasanton, CA, U.S.A.) attached to the patient's fingers or toes in a position relative to the intra-arterial line so as to avoid the effects of a patent ductus arteriosus. Oximeter probes on adjacent digits were separated by a sheet of opaque material to prevent inaccuracy due to light scattering.
After the reading of the TcCO 2 monitor stabilized, five sets of readings were taken at one-minute intervals in order to determine patient stability. In most patients, the series of five sets of measurements was made twice. The second set of measurements were obtained at a time when the patient's core-skin temperature gradient differed by more than approximately 1°C from their original core-skin temperature gradient. This generally occurred within two to 24 hours. Each set of measurements consisted of core and skin temperature, transcutaneous PCO 2 (TcCO 2 ), oxygen saturation from the Hewlett Packard monitor (Sat-HP) and oxygen saturation from the Nellcor monitor (Sat-N). A blood sample was drawn from the intra-arterial catheter at the third minute and analysed using a Bayer 865 Blood Gas Analyser (Bayer Corporation, Pittsburgh, Pennsylvania, U.S.A.): P a CO 2 as well as functional oxygen saturation (S a O 2 ) were measured in the blood sample by a co-oximeter in the Bayer analyser. Functional oxygen saturation was used because Nellcor based oximeters, like both of those used in this study, are more closely related to functional than to fractional oxygen saturation 5 . Patients were excluded if any of TcCO 2 , oxygen saturation or heart rate were not stable during this five-minute monitoring period. Data was considered unstable if TCO 2 readings varied by more than 2 mmHg or if pulse oximeter readings varied by more than 2% during the five-minute recording period. The frequency with which the pulse oximeters failed to display the pulse rate or saturation was determined from the entire data set (before exclusions).
Accuracy was determined by calculating the difference between TcCO 2 and PCO 2 (dCO 2 =TcCO 2 -PCO 2 ), the difference between Sat-HP and S a O 2 (dSO 2 -HP=Sat-HP-S a O 2 ) and the difference between Sat-N and S a O 2 (dSO 2 -N= Sat-N-S a O 2 ) after rounding to the nearest integer to match the precision of the transcutaneous PCO 2 monitor and pulse oximeters. The mean differences (bias) (dCO 2 , dSO 2 -HP and dSO 2 -N) and their standard deviations as well as their limits of agreement (bias±1.96x standard deviation) were then calculated. The influence of skin temperature, core temperature and core-skin temperature gradient on accuracy was formally analysed by regression against toe and core temperature with a regression model using the GEE method (Stata Statistical Package, v6.0, Stata Corporation, College Station, TX, U.S.A.). This method takes repeated measures (from the same subject) into account. If this formal analysis fails to find any significant effect, simple correlation can be used to summarize the data. The correlation between each of the differences (dCO 2 , dSO 2 -HP and dSO 2 -N) and each of core temperature, skin temperature and core-skin gradient was also determined.
RESULTS
Five patients were excluded: two patients had unstable pulse oximeter readings, one patient had low (<75%) Hewlett Packard pulse oximeter readings and two had unstable TCO 2 readings. Forty-six (46) patients were included in the study generating 79 sets of data. A second set of measurements were available from 33 patients with single sets of measurements available from the remaining 13 patients. Ages ranged from three to 405 days. All patients had undergone cardiac surgery immediately prior to the recording of data. All patients underwent cardiopulmonary bypass. Core temperatures ranged from 35.3°C to 39.4°C (mean 37.2°C, SD 0.80C), skin temperatures ranged from 27.0°C to 37.4°C (mean 33.4°C, SD 2.80C) and core-skin temperature gradients ranged from 0.1°C to 10.1°C (mean 3.9°C, SD 2.40C). P a CO 2 ranged from 23 mmHg to 52 mmHg while S a O 2 ranged form 77% to 100%. Two outlying points were excluded from the analysis: one point from the dCO 2 data with a value of 19 mmHg and a second point from the HP-SO 2 data with a value of 16%.
The mean differences±standard deviations and limits of agreement for dCO 2 , dSO 2 -HP and dSO 2 -N were 0.95±4.10 mmHg (-7.09 mmHg to 8.99 mmHg), -1.07±1.84% (-4.68% to 2.54%) and -1.23±2.23% (-5.60% to 3.14%) respectively.
Regression analysis failed to find any significant effects (P>0.2 except for dSO 2 -HP and toe temperature where P=0.066) of toe or core temperature on the accuracy of any of the devices studied.
The correlation coefficients between dCO 2 and core-skin gradient, skin temperature and core temperature were 0.0587, -0.0507 and 0.0036 respectively and indicate no relationship between the variables. The relationship between dCO 2 and skin temperature is shown in Figure 1 . Of the patients studied, a significant (>10%) drift was identified in the transcutaneous monitor after use on four occassions. The dCO 2 measurements for these subjects were: 7 mmHg, 6 mmHg, 5 mmHg and -8 mmHg. If the drift was removed the respective dCO 2 readings would have been 1 mmHg, -2 mmHg, -4 mmHg and -2 mmHg.
The relationships between dSO 2 -HP and skin temperature and dSO 2 -N and skin temperature are shown in Figures 2 and 3 . As with TcCO 2 , no relationship was found. The correlation coefficients between dSO 2 -HP and core-skin gradient, skin temperature and core temperature were 0.1946, -0.1620 and 0.0227 respectively. The correlation coefficients between dSO 2 -N and core-skin gradient, skin tem-perature and core temperature were 0.0644, -0.0352 and 0.0662 respectively.
The HP pulse oximeter failed to record pulse rate in 23 of 427 occasions while the Nellcor failed on one of 429 occasions. Similarly the HP failed to record saturation in five of 429 occasions (from one patient with skin temperature 31.1°C, core temperature 37.2°C) while the Nellcor was unable to provide a saturation reading on one of 390 occasions (skin temperature 35.7°C, core temperature 37.4°C).
DISCUSSION
The results of the current study show that core and skin temperature varied considerably in the postoperative period both within and between patients, and could also change rapidly. We recorded core temperatures between 35.3°C and 39.4°C and skin temperatures of between 27.0°C and 37.4°C. Over this temperature range we could not find an influence of core temperature, skin temperature or core-skin temperature gradient on the accuracy of the pulse oximeters and transcutaneous monitors studied. We did, however, document a number of cases when the pulse oximeters failed to give either a pulse rate or a saturation value. The Hewlett Packard pulse oximeter was far more likely to fail to give a pulse reading than a saturation reading (23/427 vs 5/429). The newer Nellcor device fared much better than the Hewlett Packard version, failing to provide saturation (1/390) and pulse rate (1/429) readings on fewer occasions. It is also interesting to note however that the core and skin temperatures in the cases where the devices failed to give a saturation value were temperatures at which both machines gave readings at other times.
The influence of various potential indicators of reduced peripheral blood flow on the accuracy of pulse oximetry has been studied by other investigators. These studies have looked at the influence of cardiac index [6] [7] [8] , mean arterial pressure 8 , pulse pressure 9-12 , systematic vascular resistance [8] [9] [10] [11] [12] [13] and measures of finger perfusion 11, [14] [15] [16] [17] [18] . Although the results and design of these studies have varied somewhat, the results generally indicate that the accuracy of pulse oximetry decreases when flow (as measured by these parameters) is reduced.
Some studies have also reported the influence of temperature on the accuracy of pulse oximeters 6, 7, 9, 11, 13, [19] [20] [21] [22] [23] . These studies vary in a number of ways but most of them 7, 9, 11, 13, 19, 21, 23 suggest that the performance of pulse oximeters is affected by either core or peripheral temperature. Temperatures at which performance has been reported to decline have been: core <32°C 19 , core <35°C 13, 21 , peripheral <20°C 7,9 , peripheral <28°C 21 and peripheral <30°C 11 . Only four of these studies 11, 19, 21, 22 were in paediatric patients. Three of these studies 11, 19, 21 reported changes in bias in relation to a reduction in skin temperature below approximately 30°C while the study of MacNab 22 reported no effect of changes in core temperatures above 31°C. One study 19 does not report peripheral temperatures and has only 10 patients. Another study 11 does not account for repeated measurements from the same patient. It also artificially generated decreased peripheral flow in some patients by manually occluding arterial blood flow in the arm. The study of MacNab 22 has only 16 patients in their hypothermic group and does not account for repeated measurements from the same patient while the study of Iyer 21 includes only 25 subjects, all less than three months of age.
There are fewer studies that have examined the effect of reduced perfusion on transcutaneous PCO 2 monitors. Reduced performance has been reported in relation to low cardiac index 24, 25 , circulatory changes 26 , hypotension [27] [28] and increased capillary refill time 29 .
We were unable to find any study which directly examined the influence of patient temperature on the performance of transcutaneous PCO 2 monitors. We identified one paper 30 that studied the accuracy of transcutaneous PCO 2 monitors in postoperative cardiac surgical patients, but in that paper temperature measurements were not provided and patients were only included if a discrepancy of >5 mmHg existed between P ET CO 2 and TcCO 2 and were excluded if a discrepancy of >5 mmHg existed between TcCO 2 and P a CO 2 .
Because of the limitations of existing studies we decided to assess the performance of pulse oximeters and transcutaneous PCO 2 monitors in our own patient population of postoperative cardiac surgical patients. In addition, it is known that pulse oximeter performance can vary between different pulse oximeter models in low perfusion states 6, 10, 14, 17 . We therefore felt it necessary to examine the effect of body temperature on the accuracy of our own pulse oximeters, which are widely used models and of recent manufacture. Our results showed that core temperature, skin temperature and core-skin temperature gradient did not influence the accuracy of the non-invasive devices studied.
In addition to examining the effect of changes in temperature on accuracy, we also reported the overall accuracy of the two pulse oximeters and transcutaneous PCO 2 monitor. Each of the devices has a small bias. The limits of agreement for the transcutaneous PCO 2 monitor were -7.09 mmHg to 8.99 mmHg. These limits of agreement are wider than those previously reported 31 for the same device in a group of 10 neonates at an electrode temperature of 43°C, but similar to those at a higher electrode temperature. This may reflect the smaller number of subjects used in that study or differences in device performance or patient populations, with the current study including older patients in addition to neonates. The limits of agreement for the Hewlett Packard and the Nellcor pulse oximeters are -4.68% to 2.54% and -5.60% to 3.14% respectively. These are in fact narrower than previously reported 5 and may also reflect differences in patient populations or differences in pulse oximeter characteristics. These results show that the two pulse oximeters and transcutaneous PCO 2 monitor provide data of sufficient accuracy to be clinically acceptable. Although we did not specifically examine the ability of the three devices to act as trend indicators for individual patients, as this is beyond the scope of our aim, it is possible to speculate that the devices would be more accurate in an individual patient when used this way.
Our findings showing a lack of effect on accuracy of core temperature, skin temperature and core-skin temperature gradient could be explained by the fact that the temperatures that we encountered were higher than those associated with decreased performance of pulse oximeters in other studies 7, 9, 11, 13, 19, 21 . It is possible that temperature and temperature gradient are simply not sufficiently good indicators of peripheral blood flow in this group of patients. It is known for instance, that in a similar population of patients, core-skin gradient is not related to cardiac index or systemic vascular resistance index 32 . Blood flow may not have been reduced sufficiently in the temperature ranges experienced to cause any changes in the accuracy of the pulse oximeters and transcutaneous PCO 2 monitor. More direct measurements of peripheral blood flow 9, 16, 17 show that flow can be reduced to levels of approximately 8% of baseline flow before any effects on pulse oximeter performance are noticed. Pulse oximeters are designed to cope with a very small signal size and it has been shown 12 that they may detect pulses during periods of very low finger blood flow. Some studies 9, 11 have also suggested that reduction in pulse pressure alone is not as predictive of pulse oximetry failure as a reduction in pulse pressure combined with hypothermia.
Another factor which may affect pulse oximeter accuracy are low saturation levels. The study of Al Khudhairi 19 showed that errors in pulse oximetry were much greater during reductions in core temperature in patients with low saturations (<90%) than in patients with higher saturations. We avoided this potential problem by only studying patients with saturations above 75% due to the known decrease in pulse oximeter performance below this level 5 . Most (85%) of our data were obtained in patients with saturations above 90% compared to the study of Al Khudhairi 19 in which 40% of saturation readings were below 90%. Another potential limitation of the current study is the fact that not all patients had repeat measurements. This resulted from various factors including the unavailability of personnel to record data, exclusion due to instability, the removal of the rectal temperature probe or little change occurring in the core-skin temperature gradient. This should not affect the results however as fewer than one-third of patients did not have repeated measurements taken and the statistics conducted account for this. Drift in the transcutaneous monitor provides another difficulty. It is however common to any study using a transcutaneous monitor. As opposed to changes due to patient instability, the transcutaneous monitor may undergo a drift in calibration during the recording period. This information can not be used clinically because it can only be obtained after the event. We present details here however as a simple measure of the incidence and significance of the problem.
The results of this study show, for the first time, that the accuracy of the Fastrac transcutaneous PCO 2 monitor in the postoperative period in newborns and older infants is not influenced by patient temperatures in the range usually encountered in clinical practice. Additionally, the accuracy of Hewlett Packard M1020A and Nellcor Symphony pulse oximeters is not affected by patient temperature in the same patient population in the core temperature range 35.3°C to 39.4°C and the skin temperature range 27.0°C to37.4°C. These devices are therefore acceptably accurate and suitable for use in infants after cardiac surgery.
